Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRCA
DateTimeSourceHeadlineSymbolCompany
05/07/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Reports First Quarter 2021 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
04/23/20217:04AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
04/23/20217:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
04/06/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
04/01/202112:13PMTipRanks2 “Strong Buy” Stocks Insiders Are Snapping UpNASDAQ:VRCAVerrica Parmaceuticals Inc
03/29/20219:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/29/20217:30AMGlobeNewswire Inc.Verrica Announces Election of Gary Goldenberg, MD, Verrica’s Chief Medical Officer, to Membership in the American Dermatolo...NASDAQ:VRCAVerrica Parmaceuticals Inc
03/23/20215:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/23/20215:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/22/20219:31PMGlobeNewswire Inc.Verrica Announces Pricing of Public Offering of Common StockNASDAQ:VRCAVerrica Parmaceuticals Inc
03/22/20214:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/22/20214:01PMGlobeNewswire Inc.Verrica Announces Proposed Public Offering of Common StockNASDAQ:VRCAVerrica Parmaceuticals Inc
03/17/20214:25PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/17/20218:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/17/20217:00AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercial...NASDAQ:VRCAVerrica Parmaceuticals Inc
03/04/20218:30AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/04/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20215:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20215:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20215:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20215:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20215:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
03/03/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
02/23/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
02/17/20217:30AMGlobeNewswire Inc.Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of M...NASDAQ:VRCAVerrica Parmaceuticals Inc
02/16/20214:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
01/25/20215:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
01/19/20217:00AMGlobeNewswire Inc.Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscu...NASDAQ:VRCAVerrica Parmaceuticals Inc
12/28/20205:34AMTipRanksVerrica Resubmits FDA Drug Application For Skin Therapy; Street Sees 63% UpsideNASDAQ:VRCAVerrica Parmaceuticals Inc
12/23/20204:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA